VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants.

The first case of hereditary fibrinogen Aα-chain amyloidosis was recognized >20 years ago, but disease mechanisms still remain unknown. Here we report detailed clinical and proteomics studies of a French kindred with a novel amyloidogenic fibrinogen Aα-chain frameshift variant, Phe521Leufs, causing a severe familial form of renal amyloidosis. Next, we focused our investigations to elucidate the molecular basis that render this Aα-chain variant amyloidogenic. We show that a 49-mer peptide derived from the C-terminal part of the Phe521Leufs chain is deposited as fibrils in the patient's kidneys, establishing that only a small portion of Phe521Leufs directly contributes to amyloid formation in vivo. In silico analysis indicated that this 49-mer Aα-chain peptide contained a motif (VLITL), with a high intrinsic propensity for β-aggregation at residues 44 to 48 of human renal fibrils. To experimentally verify the amyloid propensity of VLITL, we generated synthetic Phe521Leufs-derived peptides and compared their capacity for fibril formation in vitro with that of their VLITL-deleted counterparts. We show that VLITL forms typical amyloid fibrils in vitro and is a major signal for cross-β-sheet self-association of the 49-mer Phe521Leufs peptide identified in vivo, whereas its absence abrogates fibril formation. This study provides compelling evidence that VLITL confers amyloidogenic properties to Aα-chain frameshift variants, yielding a previously unknown molecular basis for the pathogenesis of Aα-chain amyloidosis.

[1]  Roland Riek,et al.  The activities of amyloids from a structural perspective , 2016, Nature.

[2]  M. Benson,et al.  Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosis , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[3]  P. Talmud,et al.  D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile , 2016, Nature Communications.

[4]  B. Ahmad,et al.  Curcumin promotes fibril formation in F isomer of human serum albumin via amorphous aggregation. , 2015, Biophysical chemistry.

[5]  F. Kametani,et al.  The first pure form of Ostertag-type amyloidosis in Japan: a sporadic case of hereditary fibrinogen Aα-chain amyloidosis associated with a novel frameshift variant , 2015, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[6]  P. Hawkins,et al.  Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations , 2014, Human mutation.

[7]  Silvio C. E. Tosatto,et al.  PASTA 2.0: an improved server for protein aggregation prediction , 2014, Nucleic Acids Res..

[8]  Rustem I. Litvinov,et al.  Mechanisms of fibrin polymerization and clinical implications. , 2013, Blood.

[9]  Stavros J. Hamodrakas,et al.  A Consensus Method for the Prediction of ‘Aggregation-Prone’ Peptides in Globular Proteins , 2013, PloS one.

[10]  M. Bolognesi,et al.  Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. , 2012, The New England journal of medicine.

[11]  S. Nasr,et al.  Laser microdissection and mass spectrometry–based proteomics aids the diagnosis and typing of renal amyloidosis , 2012, Kidney international.

[12]  M. Delpech,et al.  Synchrotron x-ray microdiffraction reveals intrinsic structural features of amyloid deposits in situ. , 2011, Biophysical journal.

[13]  M. Borggrefe,et al.  Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: Fibrinogen Mannheim V , 2009, Thrombosis and Haemostasis.

[14]  C. Zeng,et al.  Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis. , 2009, Journal of the American Society of Nephrology : JASN.

[15]  A. Esteras-Chopo,et al.  Hacking the Code of Amyloid Formation , 2007, Prion.

[16]  L. Serpell,et al.  Diffraction to study protein and peptide assemblies. , 2006, Current opinion in chemical biology.

[17]  A. Esteras-Chopo,et al.  The amyloid stretch hypothesis: recruiting proteins toward the dark side. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Hawkins,et al.  Hereditary amyloidosis in early childhood associated with a novel insertion-deletion (indel) in the fibrinogen Aalpha chain gene. , 2005, Kidney international.

[19]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[20]  M. R. Nilsson.  Techniques to study amyloid fibril formation in vitro. , 2004, Methods.

[21]  William J Welsh,et al.  Detecting hidden sequence propensity for amyloid fibril formation , 2004, Protein science : a publication of the Protein Society.

[22]  Salvador Ventura,et al.  Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Brennan,et al.  Novel Aα chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization , 2003, Journal of thrombosis and haemostasis : JTH.

[24]  M. Margaglione,et al.  A Frameshift Mutation in the Human Fibrinogen Aα-chain Gene (Aα [499] Ala Frameshift Stop) Leading to Dysfibrinogen San Giovanni Rotondo , 2001, Thrombosis and Haemostasis.

[25]  J. Liepnieks,et al.  Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein. , 1997, Blood.

[26]  J. Liepnieks,et al.  A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis. , 1996, Blood.

[27]  J. Soria,et al.  The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome". , 1996, The Journal of clinical investigation.

[28]  J. Liepnieks,et al.  Hereditary renal amyloidosis with a novel variant fibrinogen. , 1994, The Journal of clinical investigation.

[29]  D. Booth,et al.  Human lysozyme gene mutations cause hereditary systemic amyloidosis , 1993, Nature.

[30]  J. Soria,et al.  Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia. , 1993, The Journal of clinical investigation.

[31]  J. Liepnieks,et al.  Hereditary renal amyloidosis associated with a mutant fibrinogen α–chain , 1993, Nature Genetics.

[32]  M. Margaglione,et al.  A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo. , 2001, Thrombosis and haemostasis.

[33]  J. Liepnieks,et al.  Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. , 1993, Nature genetics.